Site-Defined PTM PeptidesMulti-PTM Peptide PanelsMatched Control PeptidesPTM-Focused QC Support
At Creative Peptides, we provide custom post-translational modification services for research teams that need chemically defined peptides with precise modification sites, consistent composition, and decision-ready analytical data. Our workflow supports single-site and multi-site PTM peptide preparation for phosphorylation, acetylation, methylation, glycosylation, sulfation, lipidation, and other project-relevant formats evaluated case by case. By combining peptide synthesis, peptide modification services, PTM-aware purification, and application-aligned characterization, we help biotech, pharma, academic, and assay development teams move from sequence design to assay-ready modified peptides with greater control over site, state, and comparability.
Many PTM-related research programs stall not because the biology lacks relevance, but because the material used to study it is too variable. Native samples often contain mixed modification occupancy, overlapping proteoforms, unstable PTM states, or multiple nearby candidate sites, making it difficult to assign a clear functional readout to one defined molecular event.
Our post-translational modification service helps address these research bottlenecks by:
We build PTM peptide projects around the actual scientific question rather than treating every modified sequence as a routine synthesis request. Whether you need a single phosphopeptide, a histone-inspired modification ladder, a glycopeptide standard, or a panel of matched analogs for structure-function comparison, our team can configure a practical route with the right balance of construct design, purification strategy, and analytical depth. Projects may start from a client-supplied target sequence or be integrated with our custom peptide synthesis platform for de novo construct development.
Successful PTM peptide production starts with a clear design review. We assess sequence length, modification position, terminal format, residue environment, and the number of PTMs needed in the same construct before proposing a synthesis route.
This front-end planning is particularly valuable when a project needs to isolate the effect of a single PTM variable from several plausible alternatives.
Phosphorylation remains one of the most requested PTM formats for signaling, kinase, phosphatase, and reader-domain studies. We support site-defined phosphopeptide preparation from simple mono-phosphorylated constructs to more demanding multi-phosphorylated analogs.
These constructs are commonly requested for enzyme assays, phospho-reader profiling, binding comparisons, and phospho-specific analytical workflows.
Acetylation and methylation projects often require more than simply inserting one modified residue. The scientific value usually depends on whether the exact position, charge state, and methylation level are defined correctly.
This service is especially useful when small changes in PTM state can strongly alter recognition behavior or assay output.
Certain PTM categories place greater demands on building-block selection, protecting-group logic, purification, and post-production handling. We support defined glycopeptide and sulfated peptide projects with route selection aligned to feasibility and use case.
These projects benefit from early discussion of assay buffer, storage, and analytical requirements so the final construct is fit for purpose.
A single modified peptide is not always enough to answer the biological question. Many teams need a small, well-designed panel that compares site variants, PTM combinations, or modified versus unmodified states under the same analytical framework.
This approach helps reduce ambiguity and gives researchers a more useful experimental set than a single isolated target.
Some PTM peptide programs also require a defined detection or capture handle in addition to the biological modification itself. We can configure orthogonal add-ons without losing focus on PTM placement and interpretability.
The goal is to keep the PTM as the biological variable while making the peptide more usable in the intended assay system.
PTM peptides often need more than routine purity testing. We align purification and release data with the chemistry and the way the material will be used in research.
Stronger characterization helps teams compare analogs more confidently and transfer materials into downstream workflows with less uncertainty.
Different PTM classes create different synthesis and interpretation challenges. The table below summarizes the formats most frequently requested in PTM peptide projects and the practical considerations that often shape route selection.
| PTM Format | Typical Residue / Position | Common Research Use | Key Technical Consideration | Recommended Comparison Set |
|---|---|---|---|---|
| Phosphorylation | Ser, Thr, Tyr | Kinase and phosphatase assays, signaling studies, phospho-reader profiling, LC-MS references | Closely spaced phosphosites and highly acidic sequences can complicate coupling, purification, and yield | Unmodified parent, site-isomer controls, partial phosphorylation variants |
| Acetylation | N-terminus, Lys side chain | Histone-related binding studies, acetyl-reader assays, enzyme-state comparison | Exact placement matters because terminal acetylation and lysine acetylation affect charge and recognition differently | Non-acetylated parent, alternate-site acetylated analogs |
| Methylation | Lys, Arg | Chromatin biology, reader specificity studies, enzyme assays | Mono-, di-, and trimethyl states must be explicitly distinguished during design and QC | State ladder such as Kme1, Kme2, Kme3 or matched unmethylated control |
| Glycosylation | Defined glycan-bearing residues, commonly Asn, Ser, or Thr depending on construct | Glycan-mediated recognition, receptor binding, antibody or lectin studies | Glycan identity, linkage, and peptide length strongly influence feasibility, purification, and analysis | Aglycone parent, alternate glycoforms, simplified glycan controls |
| Tyrosine Sulfation | Tyr | Receptor and chemokine binding studies, interaction mapping | Sulfate-bearing peptides require PTM-aware handling because the modification can be comparatively fragile | Non-sulfated parent, site-swap or adjacent-site controls |
| Lipidation | N-terminus, Cys, Lys, or linker-defined site | Membrane interaction studies, localization research, property tuning | Hydrophobicity gain may reduce solubility and complicate chromatographic recovery | Non-lipidated parent and linker-only comparator |
PTM peptide projects move more efficiently when the request defines not only the sequence, but also the exact modification state, comparison logic, and downstream use. The first table below shows the inputs that most directly affect feasibility and analytical planning.
| Project Input | Why It Matters | Typical Options | Useful Project Output |
|---|---|---|---|
| Sequence Boundaries | Peptide length and motif context influence feasibility, folding tendency, and assay relevance | Minimal motif, flanking-sequence construct, longer epitope segment | Recommended construct length and terminal format |
| Exact PTM Site and State | The biological interpretation depends on site specificity and the correct modification state | pSer vs pThr, N-Ac vs Lys(Ac), Kme1 vs Kme3, defined glycoform | Site-defined synthesis map and expected mass profile |
| Single vs Multi-PTM Design | Complexity increases quickly when more than one modification must be installed and compared | One-site target, paired PTMs, PTM matrix or crosstalk panel | Recommended build strategy and comparator set |
| Terminal Format and Extra Chemistry | Termini and optional handles can alter charge, solubility, detection, and assay compatibility | Free acid, amide, N-terminal cap, spacer, biotin, fluorophore, isotope label | Final construct definition suitable for the intended workflow |
| Control Peptide Requirement | Modified peptides are more informative when compared against a deliberate reference set | Unmodified parent, site-isomer, partially modified, alternate-state analog | Cleaner interpretation of binding, enzyme, or analytical data |
| Analytical and Handling Expectations | PTM category and assay format determine what release data and storage guidance are most helpful | HPLC, LC-MS, UV review, amino acid analysis, PTM-sensitive storage notes | More useful QC package for assay transfer and internal review |
In many cases, the most productive ordering strategy is to request the target PTM peptide together with a small comparison set rather than as a standalone sequence. The table below links common research goals to practical peptide-set design.
| Research Goal | Recommended Peptide Set | Typical Readouts | Why the Set Is Useful |
|---|---|---|---|
| Kinase or Phosphatase Study | Phosphorylated target, unmodified parent, and nearby site-isomer controls | Enzyme turnover, binding comparison, LC-MS signal tracking | Helps separate true site preference from general sequence recognition |
| Reader-Domain or Chromatin Binding Assay | Acetylated or methylated target plus state ladder or alternate-site analogs | SPR, BLI, fluorescence, pull-down, competition binding | Clarifies whether recognition depends on PTM state, position, or both |
| PTM-Specific Antibody Validation | Modified target, non-modified parent, and neighboring-site controls | ELISA-format assays, dot blot, competitive binding, capture workflows | Reduces the risk of reporting sequence binding as PTM specificity |
| LC-MS / Quantitative Proteomics Support | Native PTM peptide and, where useful, isotope-labeled analog | Retention-time confirmation, transition development, peak assignment | Improves method development and comparability across runs |
| PTM Crosstalk Mapping | Single-PTM peptides plus multi-PTM combinations built on the same parent sequence | Binding series, enzyme-state comparison, structural or biophysical screening | Shows whether one modification enhances, masks, or redirects the effect of another |
| Glycopeptide or Sulfated-Peptide Recognition Study | Modified target with aglycone or non-sulfated comparator and optional glycoform variants | Receptor binding, recognition assays, analytical comparison | Helps quantify the direct contribution of the PTM to the observed signal |
Site-Defined Construct Design
We organize projects around the exact PTM site, state, and comparison logic needed for interpretable data, not just around a modified sequence alone.
Support for Single and Multi-PTM Workflows
From one modified peptide to a crosstalk-focused panel, we can configure projects that compare PTM states side by side under the same analytical framework.
PTM-Aware Purification Strategy
Acidic, hydrophobic, glycan-bearing, or otherwise sensitive constructs are approached with purification logic selected for the chemistry rather than by default methods alone.
Matched Controls for Better Interpretation
We frequently recommend unmodified, alternate-site, or alternate-state controls so your final peptide set is more useful in binding, enzyme, and analytical studies.
Flexible Assay Integration
Stable isotope, fluorescence, and affinity-handle options can be added where needed to support LC-MS, capture, or readout-oriented workflows without losing PTM clarity.
Practical Documentation and Communication
Each project is planned with the downstream user in mind so the delivered material, QC package, and handling guidance support easier handoff into research workflows.
Our workflow is designed to convert a PTM question into a useful experimental peptide set with clear construct definition, relevant controls, and fit-for-purpose analytical support.
1
Sequence Intake and Scientific Scoping
2
PTM Route Assessment and Construct Definition
3
Synthesis of Modified Peptides and Controls
4
Purification and Identity Confirmation
5
PTM-Focused QC Review and Handling Guidance
6
Delivery and Follow-On Expansion
PTM peptides are most valuable when a project needs a defined molecular state rather than a heterogeneous biological mixture. Below are representative research directions where post-translational modification services provide practical value.
Post-translational modifications (PTMs) are chemical modifications made to a peptide or protein after its synthesis, which are essential for regulating its activity, stability, and interaction with other molecules. These modifications play a key role in biological processes like protein folding, signaling, and enzyme activity.
PTMs can alter the peptide's physicochemical properties, such as charge, hydrophobicity, and conformation. These changes can enhance or inhibit the peptide's ability to interact with target proteins or other biomolecules, thereby modulating its biological activity and specificity.
PTMs occur in various cellular compartments. For example, glycosylation happens in the endoplasmic reticulum (ER) and Golgi apparatus, phosphorylation typically occurs in the cytoplasm or nucleus, and acetylation often takes place on histones in the nucleus, influencing gene expression.
We offer a wide range of PTM services, including phosphorylation, glycosylation, acetylation, sulfation, hydroxylation, and prenylation. Each of these modifications can be performed enzymatically or chemically to meet specific research needs.
PTMs are crucial in protein engineering as they can enhance protein function, stability, and specificity. By introducing modifications like phosphorylation or acetylation, peptides can be engineered for better performance in various applications, such as proteomics, biomarker discovery, and structural studies.
Yes, we specialize in synthesizing peptides with multiple PTMs, providing flexibility in designing peptides with enhanced properties for specific research applications, such as improved binding affinity or better solubility.
If your team needs a reliable partner for phosphorylated peptides, acetylated or methylated analogs, glycopeptides, sulfated peptides, isotope-labeled PTM references, or multi-PTM comparison panels, Creative Peptides can support your project with practical route planning, PTM-aware analytics, and research-focused technical communication. Contact us today to discuss your target sequence, modification site, control strategy, and analytical requirements.
